Volume 64, Issue 1, Pages (July 2013)

Slides:

Advertisements

Similar presentations

Early Detection of Prostate Cancer in 2007

Advertisements

Volume 58, Issue 3, Pages (September 2010)

Volume 55, Issue 1, Pages 1-8 (January 2009)

Prostate cancer mortality in screen and clinically detected prostate cancer: Estimating the screening benefit Pim J. van Leeuwen, David Connolly, Anna.

The PSA Era is not Over for Prostate Cancer

Volume 59, Issue 2, Pages (February 2011)

Volume 57, Issue 1, Pages (January 2010)

Volume 71, Issue 6, Pages (June 2017)

Volume 50, Issue 1, Pages (July 2006)

Volume 52, Issue 1, Pages (July 2007)

Volume 62, Issue 5, Pages (November 2012)

Volume 70, Issue 6, Pages (December 2016)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 55, Issue 3, Pages (March 2009)

Volume 70, Issue 1, Pages (July 2016)

Volume 64, Issue 1, Pages (July 2013)

Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer Marisa Warmuth,

Volume 68, Issue 5, Pages (November 2015)

Yair Lotan, Peter C. Black, Laura Caba, Sam S. Chang, Michael S

Let the Games Begin (with EAU Approval)

Volume 61, Issue 2, Pages (February 2012)

Prostate Cancer Epidemic in Sight?

Volume 65, Issue 6, Pages (June 2014)

Volume 45, Issue 4, Pages (April 2004)

Volume 74, Issue 1, Pages (July 2018)

Volume 61, Issue 3, Pages (March 2012)

Volume 63, Issue 4, Pages (April 2013)

Volume 61, Issue 2, Pages (February 2012)

Volume 71, Issue 6, Pages (June 2017)

The Global Risk of Bladder Cancer: Let's Just Do Something About It!

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 70, Issue 3, Pages (September 2016)

Prostate Cancer Detection: A View of the Future

Volume 56, Issue 2, Pages (August 2009)

P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes European Urology

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 63, Issue 5, Pages (May 2013)

Volume 69, Issue 3, Pages (March 2016)

Volume 70, Issue 1, Pages (July 2016)

Volume 55, Issue 3, Pages (March 2009)

Volume 70, Issue 5, Pages (November 2016)

Volume 66, Issue 6, Pages (December 2014)

Volume 52, Issue 2, Pages (August 2007)

Prostate Cancer Epidemic in Sight?

The PSA Era is not Over for Prostate Cancer

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 66, Issue 2, Pages (August 2014)

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 70, Issue 6, Pages (December 2016)

The Economic Costs of Overactive Bladder in Germany

Is It Necessary to Detect All Prostate Cancers in Men with Serum PSA Levels

Volume 62, Issue 6, Pages (December 2012)

Volume 48, Issue 6, Pages (December 2005)

Volume 64, Issue 4, Pages (October 2013)

Volume 50, Issue 5, Pages (November 2006)

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Testicular Cancer Variations in Time and Space in Europe

Volume 59, Issue 4, Pages (April 2011)

European Urology is “Your” Journal

Thomas Steuber, Matthew Frank O'Brien, Hans Lilja European Urology

Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.

Economic Burden of Bladder Cancer Across the European Union

Georges-Pascal Haber, Sebastien Crouzet, Inderbir S. Gill

Volume 52, Issue 6, Pages (December 2007)

Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

Volume 54, Issue 3, Pages (September 2008)

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 64, Issue 1, Pages 41-47 (July 2013) Outcomes of a Bladder Cancer Screening Program Using Home Hematuria Testing and Molecular Markers Chris H. Bangma, Stacy Loeb, Martijn Busstra, Xiaoye Zhu, Samira El Bouazzaoui, Jeanine Refos, Kirstin A. Van Der Keur, Stephen Tjin, Conja G.A.M. Franken, Geert J.L.H. van Leenders, Ellen C. Zwarthoff, Monique J. Roobol European Urology Volume 64, Issue 1, Pages 41-47 (July 2013) DOI: 10.1016/j.eururo.2013.02.036 Copyright © 2013 European Association of Urology Terms and Conditions

Fig. 1 Bladder Cancer Urine Marker Project (BLU-P) flow chart. BCa=bladder cancer; CH3=methyl group CH3; FGFR3=fibroblast growth factor receptor 3; MA=microsatellite analysis; NMP22=nuclear matrix protein 22. European Urology 2013 64, 41-47DOI: (10.1016/j.eururo.2013.02.036) Copyright © 2013 European Association of Urology Terms and Conditions